WYC-210

CAS No. 2131803-93-3

WYC-210( —— )

Catalog No. M22099 CAS No. 2131803-93-3

WYC-210 is a retinoid compound,and with lower anticancer activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 238 In Stock
5MG 216 In Stock
10MG 315 In Stock
25MG 508 In Stock
50MG 686 In Stock
100MG 930 In Stock
200MG 1256 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    WYC-210
  • Note
    Research use only, not for human use.
  • Brief Description
    WYC-210 is a retinoid compound,and with lower anticancer activity.
  • Description
    WYC-210 is a retinoid compound,and with lower anticancer activity.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2131803-93-3
  • Formula Weight
    340.4
  • Molecular Formula
    C18H16N2O3S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC1(C)CCS(=O)c2ccc(cc12)C#Cc1ncc(cn1)C(O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Cao, Xin, et al. Preparation of the retinoid compound and their application as anticancer agents. WO2017152725A1.
molnova catalog
related products
  • IGF-I 30-41

    IGF-I (30-41) is amino acids 30 to 41 fragment of Insulin-like Growth Factor I (IGF-I).

  • Kresoxim-Methyl

    Kresoxim-methyl is a strobilurin fungicideinhibits conidial germination of V. inaequalis isolates from apple orchards .

  • (R)-Naroparcil

    (R)-Naroparcil is an isomer of Naroparcil. Naroparcil, a 4-methylumbelliferyl beta-D-xyloside analog, is associated with vascular smooth muscle cell proliferation and inhibits thrombus formation in the Wessler slough model.